Orkambi, a New Cystic Fibrosis Drug, Wins F.D.A. Approval by ANDREW POLLACK

By ANDREW POLLACK

The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.

Published: July 3, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1HyZ3p4

from WordPress http://ift.tt/1JCmdua
via Hadi Aboukhater